Bluebird’s gene therapy for beta-thalassemia falls short of a cure, but still wows in 22 patients
After going back to the drawing board to come up with a better gene therapy for beta-thalassemia, a disease that interferes with the body’s ability …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
